Industry News
Surprising Discovery In Mouse Model Reveals That An Anti-Cancer Gene Also Fights Obesity
Mar 08, 2012
This result, obtained after five years' research, is published in leading journal Cell Metabolism. The authors, led by Manuel Serrano (CNIO), believe it will open the door to new therapeutic options not only against cancer, but against obesity and even the ageing process... Read More
Cancer Vaccines And The Challenges They Present
Mar 08, 2012
The first therapeutic cancer vaccine has now been approved by the FDA, and a diverse range of therapeutic cancer vaccines directed against a spectrum of tumor-associated antigens are currently being evaluated in clinical trials, according to a review published in the Journal of the National Cancer Institute... Read More
How Protein Machinery Binds And Wraps DNA To Start Replication
Mar 08, 2012
Before any cell - healthy or cancerous - can divide, it has to replicate its DNA. So scientists who want to know how normal cells work - and perhaps how to stop abnormal ones - are keen to understand this process. As a step toward that goal, scientists at the U.S... Read More
Footloose And Cancer Free - Mice With Pten
Mar 08, 2012
In a perfect world, we could eat to our heart's content without sacrificing our health and good looks, and now it appears that maybe we can. Mice with an extra dose of a known anti-cancer gene lose weight even as their appetites grow... Read More
Advanced Melanoma: Using Patients' Own Anti-Tumor Cells Holds Treatment Promise
Mar 08, 2012
Results of a small trial published online on 5 March in the Proceedings of the National Academy of Sciences, where patients with progressive metastatic melanoma were treated with billions of lab-grown clones of the their own anti-tumor cells, are raising hopes that a treatment can be developed to knock back the advanced form of this most dangerous skin cancer... Read More
CYP2D6 Genotype Not Found To Predict Tamoxifen Benefit In Breast Cancer
Mar 08, 2012
Two studies published in the Journal of the National Cancer Institute provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness of CYP2D6 testing for deciding whether or not a patient should receive adjuvant tamoxifen for treatment of early-stage breast cancer... Read More
Embryonic Development Protein Active In Cancer Growth
Mar 08, 2012
A team of scientists at the University of California, San Diego Moores Cancer Center has identified a novel protein expressed by breast cancer cells - but not normal adult tissues - that could provide a new target for future anti-cancer drugs and treatments. Led by Thomas J... Read More
Estrogen-Only HRT Protects From Breast Cancer
Mar 07, 2012
A study published in The Lancet Oncology, shows women taking Hormone Replacement Therapy (HRT) are less likely to develop breast cancer. Researchers from the Fred Hutchinson Cancer Research Center, Seattle, USA looked at data from more than 7,500 women who were enrolled in the Women's Health Initiative (WHI) trial and took HRT over a period of about six years... Read More
Estrogen-Only HRT Protects From Breast Cancer
Mar 07, 2012
A study published in The Lancet Oncology, shows women taking Hormone Replacement Therapy (HRT) are less likely to develop breast cancer. Researchers from the Fred Hutchinson Cancer Research Center, Seattle, USA looked at data from more than 7,500 women who were enrolled in the Women's Health Initiative (WHI) trial and took HRT over a period of about six years... Read More
Chronic Lymphocytic Leukemia - Aggressive Drug Combo Restores Quality Of Life
Mar 07, 2012
A clinical trial published in Leukemia & Lymphoma , has shown that patients with the most common form of adult leukemia who take an aggressive drug combination can resume a normal quality of life once treatment is completed. The Leukemia & Lymphoma Research's CLL4 trial included 777 patients who were diagnosed with chronic lymphocytic leukemia (CLL) between 1999 and 2004... Read More
Previous Page Next Page